{"schema_version":"1","generated_at":"2026-11-05T03:57:01.997Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/lisa-dunkle","json_url":"https://www.findmykol.com/kol/lisa-dunkle/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"lisa-dunkle","name":"Lisa Dunkle","credential":"MD","title":"Vice President Clinical Research","specialty":"Pediatric Infectious Diseases","specialty_raw":"Pediatric Infectious Diseases","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"Novavax","institution_url":"https://www.findmykol.com/institution/novavax","city":"Madison","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1568617918","orcid":"0000-0003-2973-0245","openalex":"A5080344225"},"summary":"Lisa Dunkle is Vice President Clinical Research at Novavax. OpenAlex indexes 122 publications with 4,296 citations (h-index 35); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Lisa Dunkle, MD, is Vice President Clinical Research at Novavax. The public record shows 122 publications with 4,296 citations (h-index 35), centered on SARS-CoV-2 and COVID-19 Research, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies.","bullets":["Most recent indexed publication: 2020 · Open forum infectious diseases","Top research focus: SARS-CoV-2 and COVID-19 Research","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 1 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"Influenza, Human","therapeutic_area":"Infectious Disease","trials":1,"topics":0,"strength":3},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Thyroid Disorders","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"HIV","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Dyslipidemia / Lipid Disorders","therapeutic_area":"Cardiology","trials":0,"topics":0,"strength":1},{"label":"Sepsis / Serious Bacterial","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1}],"research_topics":["SARS-CoV-2 and COVID-19 Research","HIV/AIDS drug development and treatment","COVID-19 Clinical Research Studies","HIV/AIDS Research and Interventions","HIV Research and Treatment"],"drugs_studied":{"total":1,"shown":1,"withheld":0,"rows":[{"name":"NOVAVAX COVID-19 VACCINE","trials":0,"payments":10,"publications":0,"mentions":10}]},"works_with":{"total":2,"shown":2,"withheld":0,"rows":[{"name":"Novavax Inc","trials":0,"payments":10,"mentions":10},{"name":"Protein Sciences Corporation","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":122,"cited_by_count":4296,"h_index":35,"i10_index":63,"pubmed_count":1,"latest_activity_year":2025,"emerging":true,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT01959945","title":"Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)","phase":"PHASE3","status":"COMPLETED","role":"Investigator","sponsor":"Protein Sciences Corporation","source_url":"https://clinicaltrials.gov/study/NCT01959945","trial_url":"https://www.findmykol.com/trial/NCT01959945"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2025,"last":2025},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Novavax Inc","program_year":2025,"amount_usd":21825,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1568617918"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1568617918","source":"payments"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":4,"years":{"first":2022,"last":2025},"societies":["IDSA"],"shown":3,"withheld":1,"rows":[{"title":"P-1655. Anti-Spike IgG4 and Fc Effector Responses: The Impact of SARS-CoV-2 Vaccine Platform–Specific Priming and Immune Imprinting","society":"IDSA","meeting":"IDWeek","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1093/ofid/ofaf695.1830","source_url":"https://doi.org/10.1093/ofid/ofaf695.1830","status":"verified"},{"title":"P-1657. Difference in reactogenicity events between mRNA and Protein-subunit Vaccines: Results from the Booster Epidemiological Evaluation of Health, Illness, and Vaccine Efficacy (BEEHIVE) Study, a U.S. randomized trial of 2023-2024 COVID-19 vaccines (XBB.1.5)","society":"IDSA","meeting":"IDWeek","year":2025,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1093/ofid/ofaf695.1832","source_url":"https://doi.org/10.1093/ofid/ofaf695.1832","status":"verified"},{"title":"P-1972. SARS-CoV-2 Vaccine–Induced IgG4 Response Negatively Correlates with Neutralizing Antibodies and Fc Effector Functions","society":"IDSA","meeting":"IDWeek","year":2024,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1093/ofid/ofae631.2130","source_url":"https://doi.org/10.1093/ofid/ofae631.2130","status":"verified"}],"source":"congress"},"publications":{"total":1,"shown":1,"withheld":0,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study.","year":2020,"journal":"Open forum infectious diseases","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/32617368/","status":"verified"}],"most_cited":{"total":122,"shown":5,"withheld":117,"rows":[{"title":"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico","year":2021,"cited_by_count":443,"type":"article","source_url":"https://doi.org/10.1056/nejmoa2116185"},{"title":"Changing Presentation of Herpes Simplex Virus Infection in Neonates","year":1988,"cited_by_count":335,"type":"article","source_url":"https://doi.org/10.1093/infdis/158.1.109"},{"title":"A Controlled Trial of Acyclovir for Chickenpox in Normal Children","year":1991,"cited_by_count":306,"type":"article","source_url":"https://doi.org/10.1056/nejm199111283252203"},{"title":"Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older","year":2017,"cited_by_count":291,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1608862"},{"title":"2',3'-Didehydro-3'-deoxythymidine (d4T) in Patients with AIDS or AIDS-Related Complex: A Phase I Trial","year":1993,"cited_by_count":164,"type":"article","source_url":"https://doi.org/10.1093/infdis/167.1.21"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Cynthia L. Gay","coauthored_works":21},{"name":"Wayne Woo","coauthored_works":19},{"name":"Karen L. Kotloff","coauthored_works":18}],"source":"works"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"linkedin","url":"https://www.linkedin.com/in/lisa-dunkle-1b193110","status":"verified"}]},"mentions":{"total":6,"shown":3,"rows":[{"url":"https://muraena.ai/profile/lisa_dunkle_45c11c75","platform":"other","status":"verified"},{"url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","platform":"other","status":"verified"},{"url":"https://rocketreach.co/lisa-dunkle-email_4407967","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":2,"shown":2,"rows":[{"value":"MD, The Johns Hopkins University School of Medicine","source_url":"https://muraena.ai/profile/lisa_dunkle_45c11c75","status":"provisional","collected_at":"2026-11-04"},{"value":"A.B., Biological Sciences, Wellesley College","source_url":"https://muraena.ai/profile/lisa_dunkle_45c11c75","status":"provisional","collected_at":"2026-11-04"}]},"awards":{"total":3,"shown":3,"rows":[{"value":"Distinguished Alumna of Johns Hopkins University (2011)","source_url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","status":"provisional","collected_at":"2026-11-04"},{"value":"Fellow, Infectious Diseases Society of America","source_url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","status":"provisional","collected_at":"2026-11-04"},{"value":"Who’s Who in America","source_url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","status":"provisional","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Chief Medical Officer, Protein Sciences Corporation (joined 2011; former)","source_url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","status":"provisional","collected_at":"2026-11-04"},{"value":"Former Professor of Pediatrics and Microbiology, St. Louis University School of Medicine","source_url":"https://ondemand.casss.org/b/sp/lisa-dunkle-2383","status":"provisional","collected_at":"2026-11-04"}]},"media":{"total":4,"shown":3,"rows":[{"value":"Remarks reported at an IZ Summit Partners event (October 10, 2019)","source_url":"https://www.izsummitpartners.org/2019-10-10/","status":"provisional","collected_at":"2026-11-04"},{"value":"Quoted in NBC News on a caterpillar-grown flu vaccine study","source_url":"https://www.nbcnews.com/health/health-news/caterpillar-grown-flu-vaccine-protects-better-egg-incubated-vaccine-n775271","status":"provisional","collected_at":"2026-11-04"},{"value":"Interviewed by Contagion on the role of Novavax's COVID-19 vaccine","source_url":"https://www.contagionlive.com/view/what-role-will-novavax-s-vaccine-play-in-the-global-covid-19-effort-","status":"provisional","collected_at":"2026-11-04"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Commented at an ACIP meeting on influenza vaccine presentations (as Protein Sciences Corporation)","source_url":"https://stacks.cdc.gov/view/cdc/76511/cdc_76511_DS1.pdf","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Filip Dubovsky","slug":"filip-dubovsky","institution":"Novavax","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/filip-dubovsky","json_url":"https://www.findmykol.com/kol/filip-dubovsky/profile.json"},{"name":"Berit Carow","slug":"berit-carow","institution":"Novavax","url":"https://www.findmykol.com/kol/berit-carow","json_url":"https://www.findmykol.com/kol/berit-carow/profile.json"},{"name":"Sofia E. Magnusson","slug":"sofia-magnusson","institution":"Novavax","url":"https://www.findmykol.com/kol/sofia-magnusson","json_url":"https://www.findmykol.com/kol/sofia-magnusson/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"congress":1,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2025 to 2025","collected_at":"2026-11-04"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}